$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
The bibliometric analysis conducted in this study provides a comprehensive mapping of the research landscape on the comorbidity between AD and AR. This approach not only highlights global research trends but also identifies key contributors, emerging themes, and potential future directions for research in this important field.
Over the past decade, publications on the comorbidity of AD and AR have shown a fluctuating upward trend, reflecting growing global interest in this field. However, after peaking in 2021 (182 publications), it declined before returning to its peak in 2024. Reviewing other bibliometric studies reveals that the decline in related research observed in 2021 was a common phenomenon13,14,15. This decline may be associated with the COVID-19 pandemic. At the National Level, the United States has been the leading contributor, publishing the most articles, followed by China and Germany. These trends demonstrate the active role of international collaborations, especially between research hubs in North America, Europe, and Asia. Institutions such as China Medical University and the University of Zurich emerged as key research centers, fostering substantial academic exchange and driving forward the knowledge base in this domain. The cluster analysis of countries, institutions, and authors revealed distinct research hubs, further underscoring the field's collaborative nature. For instance, the collaborative efforts between countries such as the United States, China, and Germany suggest a strong, interconnected research network. In the future, cooperation between countries and institutions should be further strengthened, integrating resources and professional knowledge from different regions to jointly address key unresolved issues in AD and AR comorbidity research.
An interrogation of keyword and co-occurrence patterns indicates a dynamic trajectory in the field's thematic emphasis. Research into AD and AR comorbidity was initially dominated by epidemiological studies and clinical observations, whereas recent investigations have increasingly prioritized molecular mechanisms, immune regulation, and therapeutic strategies. This evolution parallels a wider reorientation in allergic disease research, wherein the deciphering of immunological and genetic determinants has emerged as a central domain of inquiry16,17,18. Emerging evidence also highlights the role of environmental factors in allergic diseases. For instance, a recent study showed that pet ownership increases exhaled nitric oxide and asthma severity in children with atopic asthma, suggesting that environmental exposures can modulate disease expression19. Another population-based cohort study demonstrated that the atmospheric environment influences the persistence of pediatric asthma, underscoring the importance of environmental factors in the course of allergic diseases20. These findings align with the keyword clusters related to environmental triggers identified in our analysis, supporting the need for integrated research on gene-environment interactions in AD and AR comorbidity. The identification of 11 distinct keyword clusters underscores the diversity of research, encompassing immune modulation, genetics, and environmental triggers. Furthermore, the recurring centrality of "immune regulation" across these cluster points to the pivotal role of immune pathways in the AD-AR interplay. Given the shared immune dysregulation in both diseases, this immunological focus represents a promising avenue for developing integrated treatment strategies21,22.
Relevant findings from previous studies have established common molecular and immune mechanisms underlying both AD and AR, findings further supported by the present analysis. These conditions converge on a pathophysiological model of immune dysregulation, particularly involving T-helper cells, and compromise the epithelial barrier in the skin and nose, consistent with previous research findings23,24,25. Consequently, investigating these shared pathways is vital for identifying common biomarkers and therapeutic targets. The c findings highlight the central role of immune regulation, with cytokines and chemokines being critically implicated in both diseases. The co-occurrence of keywords related to immunity, inflammation, and genetics further underscores their complex etiology, in which genetic susceptibility, environmental exposures, and immune abnormalities intersect. Evidence suggests that the genetic and immunological commonalities between AD and AR allow them to mutually influence their clinical expression, potentially leading to more severe outcomes when they co-occur26,27,28. Nevertheless, substantial gaps persist in clinical practice despite significant progress in understanding the shared mechanisms of AD and AR. A major shortcoming is the absence of standardized protocols for diagnosing and treating patients with this comorbidity. Given the considerable overlap in their immunopathology, it is imperative to develop integrated strategies that concurrently manage both conditions, moving beyond a siloed approach. Future research must therefore focus on refining diagnostic criteria, enhancing therapeutic efficacy, and optimizing management for these co-occurring allergic diseases.
Several limitations should be considered when interpreting the findings of this bibliometric analysis. First, the dominance of publications from the United States, China, and Germany may introduce geographic bias, as research output does not necessarily correlate with disease burden or population diversity. Findings derived primarily from these populations may not be fully generalizable to other regions with different genetic backgrounds, environmental exposures, and healthcare infrastructures. Second, the restriction to English-language publications may exclude relevant studies published in other languages, potentially omitting valuable insights from non-English-speaking regions. Third, the use of Web of Science as the sole data source may underrepresent research published in regional journals not indexed in this database. These geographic and linguistic biases should be considered when extrapolating the conclusions to global populations. Furthermore, it should be noted that bibliometric indicators, including publication counts and citation frequencies, reflect scholarly activity and visibility rather than directly measuring research quality or clinical relevance. Similarly, keyword clusters represent statistical co-occurrence patterns that require expert interpretation and validation through a comprehensive literature review. Therefore, while this study provides a valuable data-driven overview of the field, its findings should be interpreted alongside qualitative assessments and clinical expertise.
Conclusion
This systematic review and bibliometric analysis clarify the intellectual structure and emerging research trends in AD and AR comorbidity. It highlights immune regulation and genetic factors as key themes, thereby guiding future investigations into the common mechanisms underlying both diseases. As research progresses, multidisciplinary integration and global cooperation will be critical to advancing knowledge and enhancing patient care. Moving forward, studies should prioritize bridging gaps in clinical practice, especially through the development of unified diagnostic and therapeutic approaches for individuals with coexisting AD and AR.